{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:36:05Z","timestamp":1793831765011,"version":"4.6.1"},"reference-count":152,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Geriatr Psychiatry Neurol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This is a new algorithm from the Psychopharmacology Algorithm Project at the Harvard South Shore Program, focused on generalized anxiety disorder (GAD) in older adults. Pertinent articles were identified and reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Selective serotonin reuptake inhibitors (SSRIs) are considered to be first-line medications, with a preference for sertraline or escitalopram. If avoiding sexual side effects is a priority, buspirone is an option for the relatively healthy older adult. If response is inadequate, the second recommended trial is with a different SSRI or one of the serotonin-norepinephrine update inhibitors (SNRIs), venlafaxine or duloxetine. For a third medication trial, additional alternatives added to the previous options now include pregabalin\/gabapentin, lavender oil, and agomelatine. If there is an unsatisfactory response to the third option chosen, quetiapine may be considered. We recommend caution with the following for acute treatment in this population: benzodiazepines and hydroxyzine. Other agents given low priority but having some supportive evidence were vilazodone, vortioxetine, mirtazapine, and cannabidiol. Acknowledging that the median age of onset of GAD is in early adulthood, many patients with GAD will have been started on benzodiazepines (or other medications that require caution in the elderly) for GAD at a younger age. These medications may be continued with regular observation to see if the potential harms are starting to exceed the benefits and a switch to other recommended agents may be justified.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08919887241289533","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T12:20:37Z","timestamp":1727785237000},"page":"155-171","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["A Proposed Algorithm for the Pharmacological Treatment of Generalized Anxiety Disorder in the Older Patient"],"prefix":"10.1177","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0507-9363","authenticated-orcid":false,"given":"Anderson","family":"Chen","sequence":"first","affiliation":[{"name":"Psychiatry Department, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Metzger","sequence":"additional","affiliation":[{"name":"Psychiatry Department, Hebrew Senior Life, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Psychiatry Department, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9477-241X","authenticated-orcid":false,"given":"David","family":"Osser","sequence":"additional","affiliation":[{"name":"Psychiatry Department, VA Boston Healthcare System, Brockton, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,10]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e3181ad4f5a"},{"issue":"11","key":"e_1_3_3_3_2","first-page":"15","article-title":"Generalized anxiety disorder: nature and course","volume":"62","author":"Wittchen HU","year":"2001","unstructured":"Wittchen HU, Hoyer J. Generalized anxiety disorder: nature and course. J Clin Psychiatry. 2001;62(11):15-19; discussion 20-21.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/jgp.0b013e31818f3a93"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/hrp.0000000000000098"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3928\/0048-5713-19990501-10"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108096505"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.Jgp.0000196629.19634.00"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.977301\/3\/295"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/0891988705276251"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2009.02055.x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4088"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v69n0402"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2004.06.007"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50003.x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.037788"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.3867"},{"issue":"5","key":"e_1_3_3_18_2","first-page":"536","article-title":"Treatment of anxiety with ketazolam in elderly patients","volume":"10","author":"Bresolin N","year":"1988","unstructured":"Bresolin N, Monza G, Scarpini E, et al. Treatment of anxiety with ketazolam in elderly patients. Clin Therapeut. 1988;10(5):536-542.","journal-title":"Clin Therapeut"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0033-3182(82)73363-8"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.48557"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e31806841c8"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r07757"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.3971"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114840"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113641"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12860"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/hrp.0000000000000197"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0193-953x(05)70204-5"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.3233\/jad-160979"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2013.01.006"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.113.003741"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.74"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.02.020"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2017.12.099"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-021-00475-7"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2003.06.006"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.7.1069"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15519"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1017\/s1461145712000922"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)31793-8"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S83107"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-200401000-00004"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000321079"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06111868"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/da.21970"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h569"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1211"},{"key":"e_1_3_3_49_2","volume-title":"Diagnostic Issues in Depression and Generalized Anxiety Disorder","author":"Goldberg D","year":"2010","unstructured":"Goldberg D, Kindler K, Sirovatka P, Regier D. Diagnostic Issues in Depression and Generalized Anxiety Disorder. Washington, DC: American Psychiatric Publising; 2010."},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.232"},{"issue":"1","key":"e_1_3_3_51_2","first-page":"8","article-title":"Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders. Review","volume":"67","author":"Keck PE","year":"2006","unstructured":"Keck PEJr., Strawn JR, McElroy SL. Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders. Review. J Clin Psychiatry. 2006;67(1):8-15.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2007.08.001"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1017\/s1461145709990423"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2022.20.3.403"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20997"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20010777"},{"issue":"2","key":"e_1_3_3_57_2","first-page":"72","article-title":"Prazosin outcomes in older veterans with posttraumatic stress disorder","volume":"37","author":"Khaw C","year":"2020","unstructured":"Khaw C, Argo T. Prazosin outcomes in older veterans with posttraumatic stress disorder. Fed Pract. 2020;37(2):72-78.","journal-title":"Fed Pract"},{"issue":"2","key":"e_1_3_3_58_2","first-page":"16","article-title":"Real-world data on SSRI antidepressant side effects","volume":"6","author":"Cascade E","year":"2009","unstructured":"Cascade E, Kalali AH, Kennedy SH. Real-world data on SSRI antidepressant side effects. Psychiatry. 2009;6(2):16-18.","journal-title":"Psychiatry"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107076996"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.105.012799"},{"key":"e_1_3_3_61_2","first-page":"193","volume-title":"Texbook of Anxiety Disorders","author":"Ameringen V","year":"2010","unstructured":"Ameringen V, Mancini C, Patterson B, Simpson W, Truong C. Pharmacotherapy for generalized anxiety disorder. In: Stein D, Hollander E, Rothbaum B, eds. Texbook of Anxiety Disorders. Washington, DC: American Psychiatric Publishing; 2010:193-218."},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070905"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013501994"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13081052"},{"key":"e_1_3_3_65_2","first-page":"256","volume-title":"Outpatient Management of Depression: A Guide for the Primary-Care Practioner","author":"Preskorn SH","year":"1999","unstructured":"Preskorn SH. Outpatient Management of Depression: A Guide for the Primary-Care Practioner. San Juan, Puerto Rico: Professional Communications Inc; 1999:256."},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181a5233f"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v61n1109"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G293"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2014.01.010"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011200"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0000000000000608"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02073-x"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211001082"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4551"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.7.795"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12111467"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.3208"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1199"},{"issue":"170","key":"e_1_3_3_79_2","first-page":"96","article-title":"Venlafaxine: more dangerous than most \u201cselective\u201d serotonergic antidepressants","volume":"25","author":"Editorial Staff of Prescrire","year":"2016","unstructured":"Editorial Staff of Prescrire. Venlafaxine: more dangerous than most \u201cselective\u201d serotonergic antidepressants. Prescrire Int. 2016;25(170):96-99.","journal-title":"Prescrire Int"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0000000000000701"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v64n0804"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00763-z"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113492027"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1017\/9781108975292"},{"issue":"6","key":"e_1_3_3_85_2","first-page":"33","article-title":"Efficacy and tolerability of duloxetine treatment in elderly patients with major depressive disorder and concurrent anxiety symptoms","volume":"4","author":"Russell J","year":"2007","unstructured":"Russell J, Raskin J, Wiltse C, Walker D, Brawman-Mintzer O. Efficacy and tolerability of duloxetine treatment in elderly patients with major depressive disorder and concurrent anxiety symptoms. Psychiatry. 2007;4(6):33-45.","journal-title":"Psychiatry"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.949"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.341.14013"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0000000000000604"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1159\/000110055"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072415"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.2165\/11537140-000000000-00000"},{"key":"e_1_3_3_92_2","first-page":"341","article-title":"Geriatric Depression: the use of antidepressants in the elderly. Clinical Article","volume":"53","author":"Wiese B","year":"2011","unstructured":"Wiese B. Geriatric Depression: the use of antidepressants in the elderly. Clinical Article. BC Medical Journal. 2011;53:341-347.","journal-title":"BC Medical Journal"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q405"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199908000-00010"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-013-9890-1"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10r06218blu"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318184ff5b"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08433"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07493"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01583-9"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.02.007"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0680-6"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54529-9"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1097\/yic.0000000000000176"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318291be67"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-1-200107030-00036"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21177"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21010"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244x-12-162"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v66n1016"},{"issue":"3","key":"e_1_3_3_112_2","first-page":"41","article-title":"Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trial","volume":"40","author":"Pandina GJ","year":"2007","unstructured":"Pandina GJ, Canuso CM, Turkoz I, Kujawa M, Mahmoud RA. Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trial. Psychopharmacol Bull. 2007;40(3):41-57.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v67n0307"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000248620.34541.bc"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1017\/s109285290001676x"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.07.005"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240030"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.1763"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.357"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.6.892"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04325"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199909000-00004"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.2.151"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2012.08.003"},{"key":"e_1_3_3_125_2","unstructured":"US Food & Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. 2022. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or. Accessed 10\/24\/2022."},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20m13283"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011481.pub2"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211069096"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmab143"},{"issue":"10","key":"e_1_3_3_130_2","first-page":"1015","article-title":"Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial","volume":"169","author":"Baillargeon L","year":"2003","unstructured":"Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Gr\u00e9goire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ (Can Med Assoc J). 2003;169(10):1015-1020.","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006x.75.2.325"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291703008213"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.20.2456"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050213"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.2.332"},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-007-9118-y"},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.6.498"},{"issue":"5","key":"e_1_3_3_138_2","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline","volume":"64","author":"Pottie K","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, et al. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339-351.","journal-title":"Can Fam Physician"},{"key":"e_1_3_3_139_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.23com14959"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470100303"},{"key":"e_1_3_3_141_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050731"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v63n1112"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006815.pub2"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.106"},{"key":"e_1_3_3_145_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1804-9"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16833"},{"key":"e_1_3_3_147_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105056527"},{"key":"e_1_3_3_148_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2017.01.016"},{"key":"e_1_3_3_149_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.08.009"},{"key":"e_1_3_3_150_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033161"},{"key":"e_1_3_3_151_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.580858"},{"key":"e_1_3_3_152_2","first-page":"1","volume-title":"Psychopharmacology Algorithms","author":"Osser DN","year":"2021","unstructured":"Osser DN, Patterson R. On the value of evidence-based psychopharmacology algorithms. In: Psychopharmacology Algorithms. Netherlands: Wolters Kluwer; 2021:1-6."},{"key":"e_1_3_3_153_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2014.05.002"}],"container-title":["Journal of Geriatric Psychiatry and Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08919887241289533","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08919887241289533","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08919887241289533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:16:58Z","timestamp":1777501018000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08919887241289533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":152,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1177\/08919887241289533"],"URL":"https:\/\/doi.org\/10.1177\/08919887241289533","relation":{},"ISSN":["0891-9887","1552-5708"],"issn-type":[{"value":"0891-9887","type":"print"},{"value":"1552-5708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}